Julie Parsonnet

Publication Details

• Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States.

  Rupnow MF, Chang AH, Shachter RD, Owens DK, Parsonnet J. J Infect Dis. 2009; 200 (8): 1311-7

  Helicobacter pylori vaccines are under development to prevent infection. We quantified the cost-effectiveness of such a vaccine in the United States, using a dynamic transmission model.

  PubMedID: 19751153